K Hamada

534 total citations
26 papers, 376 citations indexed

About

K Hamada is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K Hamada has authored 26 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K Hamada's work include Colorectal Cancer Treatments and Studies (4 papers), Neurological disorders and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). K Hamada is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Neurological disorders and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). K Hamada collaborates with scholars based in Japan, United States and Serbia. K Hamada's co-authors include Shuntaro Nagai, Hirohisa Watanabe, Masaaki Hirayama, Gen Sobue, Masahisa Katsuno, Yasunori Okada, Lukas Makris, Takeo Ishigaki, Hiroshi Fukatsu and T Izumi and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

K Hamada

25 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Hamada Japan 10 147 80 77 70 56 26 376
Marios Kaliakatsos United Kingdom 12 75 0.5× 64 0.8× 53 0.7× 48 0.7× 54 1.0× 31 411
Eşref Tel Türkiye 15 114 0.8× 48 0.6× 58 0.8× 18 0.3× 18 0.3× 24 418
Jane Redford United Kingdom 5 83 0.6× 76 0.9× 22 0.3× 44 0.6× 53 0.9× 5 332
Ramazan Durmaz Türkiye 14 118 0.8× 25 0.3× 44 0.6× 20 0.3× 23 0.4× 25 381
Yanqiang Wang China 12 97 0.7× 15 0.2× 63 0.8× 32 0.5× 38 0.7× 45 375
Yingjiang Gu China 10 114 0.8× 120 1.5× 24 0.3× 18 0.3× 16 0.3× 18 316
Mami Kanzaki Japan 10 322 2.2× 248 3.1× 19 0.2× 26 0.4× 26 0.5× 25 501
Carlotta Ginevra Nucci Italy 6 234 1.6× 65 0.8× 27 0.4× 18 0.3× 100 1.8× 15 395
Patricia Calleja Spain 10 68 0.5× 25 0.3× 46 0.6× 41 0.6× 14 0.3× 16 308
R. Schwendimann United States 10 69 0.5× 24 0.3× 16 0.2× 36 0.5× 30 0.5× 27 323

Countries citing papers authored by K Hamada

Since Specialization
Citations

This map shows the geographic impact of K Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Hamada more than expected).

Fields of papers citing papers by K Hamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Hamada. The network helps show where K Hamada may publish in the future.

Co-authorship network of co-authors of K Hamada

This figure shows the co-authorship network connecting the top 25 collaborators of K Hamada. A scholar is included among the top collaborators of K Hamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Hamada. K Hamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamada, K, et al.. (2021). Gastrointestinal: Lupus mesenteric vasculitis of the colon diagnosed using endoscopic biopsy. Journal of Gastroenterology and Hepatology. 36(8). 2034–2034. 1 indexed citations
2.
Saif, Muhammad Wasif, Carlos Becerra, Marwan Fakih, et al.. (2021). A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment. Cancer Chemotherapy and Pharmacology. 88(3). 485–497. 6 indexed citations
3.
Hamada, K, Shuji Yamamoto, & Hiroshi Seno. (2021). Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis. Clinical Gastroenterology and Hepatology. 20(3). e352–e353. 2 indexed citations
4.
Piha‐Paul, Sarina A., Analía Azaro, Do‐Youn Oh, et al.. (2021). A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations. Investigational New Drugs. 39(5). 1324–1334. 6 indexed citations
5.
Yamauchi, Atsushi, Tadayuki Kou, Takuya Kishimoto, et al.. (2021). Risk factor analysis for early rebleeding after endoscopic treatment for colonic diverticular bleeding with stigmata of recent hemorrhage. JGH Open. 5(5). 573–579. 5 indexed citations
6.
Varghese, Anna M., Dana B. Cardin, Al B. Benson, et al.. (2020). Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors. Clinical Cancer Research. 26(7). 1555–1562. 13 indexed citations
7.
Araki, Kunihiko, Ryoichi Nakamura, Daisuke Ito, et al.. (2020). NUS1 mutation in a family with epilepsy, cerebellar ataxia, and tremor. Epilepsy Research. 164. 106371–106371. 18 indexed citations
8.
Patel, Manish R., Gerald S. Falchook, K Hamada, et al.. (2019). Results of a phase II study evaluating trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite-stable (MSS) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 37(8_suppl). 48–48. 5 indexed citations
9.
Senda, Joe, et al.. (2010). Investigation of Inpatient Rehabilitation Outcomes in different Ischemic Stroke Disease Types : Relationships with Leukoaraiosis in MRI. The Japanese Journal of Rehabilitation Medicine. 47(8). 559–568. 1 indexed citations
10.
Nakamura, Tomohiko, Masaaki Hirayama, Hiroki Ito, et al.. (2007). Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease. Journal of the Neurological Sciences. 263(1-2). 133–138. 29 indexed citations
11.
Watanabe, Hirohisa, Hiroshi Fukatsu, Masahisa Katsuno, et al.. (2004). Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.. PubMed. 75(1). 103–9. 79 indexed citations
12.
Hamada, K. (2003). Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 74(4). 423–426. 70 indexed citations
13.
Hamada, K, et al.. (2001). Phylogenetic analysis of genotypic variations of Escherichia coli O157:H7 isolates from sporadic infections by using pulsed-field gel electrophoresis from March 1999 to February 2001 in Hyogo Prefecture.. PubMed. 54(4). 162–5. 1 indexed citations
14.
Hamada, K, et al.. (2000). [Administration of clarithromycin (CAM) to non-small cell lung cancer].. PubMed. 53 Suppl A. 52–5. 4 indexed citations
15.
Shimada, Kazuyuki, et al.. (2000). Outbreak of salmonella enteritidis caused by contaminated buns peddled by a producer using traveling cars in hyogo and neighboring prefectures in 1999: an epidemiological study using pulsed-field gel electrophoresis.. PubMed. 53(1). 23–4. 2 indexed citations
16.
Hamada, K, et al.. (1999). Salmonella Oranienburg involved in a variety of diseases.. PubMed. 52(5). 219–219. 2 indexed citations
17.
Hamada, K, et al.. (1999). Bone mineral density and vitamin D in patients with sarcoidosis.. PubMed. 16(2). 219–23. 8 indexed citations
18.
Hamada, K, et al.. (1998). Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis. European Respiratory Journal. 11(5). 1015–1020. 23 indexed citations
19.
Kita, Eisuke, Mitsuru Konishi, K Hamada, et al.. (1993). Effect of Erythromycin on Production of Cytotoxin and Attachment Factors of Bacteria. Kansenshogaku zasshi. 67(7). 648–653. 1 indexed citations
20.
Uchida, Seijiro, et al.. (1978). Studies on virus-inhibiting substances of bacterial origin. III. Antiviral substance extractable from Streptococcus faecalis: its in vitro activities and some biological characteristics.. PubMed. 24(2). 99–114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marios Kaliakatsos Breakdown of academic impact, for papers by Eşref Tel Breakdown of academic impact, for papers by Jane Redford Breakdown of academic impact, for papers by Ramazan Durmaz Breakdown of academic impact, for papers by Yanqiang Wang Breakdown of academic impact, for papers by Yingjiang Gu Breakdown of academic impact, for papers by Mami Kanzaki Breakdown of academic impact, for papers by Carlotta Ginevra Nucci Breakdown of academic impact, for papers by Patricia Calleja Breakdown of academic impact, for papers by R. Schwendimann
Rankless by CCL
2026